Vimarsana
Biggest News Aggregation in the World

Page 48 - Astrazeneca Evusheld News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Astrazeneca Evusheld. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Astrazeneca Evusheld Today - Breaking & Trending Today

Biden administration announces additional purchase of 500,000 AstraZeneca Covid-19 treatment courses - Vimarsana News

Biden administration announces additional purchase of 500,000 AstraZeneca Covid-19 treatment courses

AstraZeneca's Evusheld is a drug aimed at helping immune-compromised people from getting infected with the coronavirus.

Source: komu.com
U.S. sends states monoclonal antibodies that might not work against omicron - Vimarsana News

U.S. sends states monoclonal antibodies that might not work against omicron

The federal government has resumed shipping all three monoclonal antibody treatments—including one made by Indianapolis-based Eli Lilly and Co.—that are authorized for early-stage COVID-19 to states despite evidence that two might be ineffective against the omicron variant.

Source: ibj.com
Setbacks, shortages undercut our options for treating Covid-19 - Vimarsana News

Setbacks, shortages undercut our options for treating Covid-19

Doctors have an arsenal of different Covid-19 treatments, but setbacks and shortages are undercutting the options.

UW Health gets oral COVID treatment doses, doctor discusses - Vimarsana News

UW Health gets oral COVID treatment doses, doctor discusses

UW Health, like many hospital systems, will be allocated doses of the recently authorized oral therapeutics to treat COVID-19.

What will COVID-19 be like in 2022? More vaccines and masks - Vimarsana News

What will COVID-19 be like in 2022? More vaccines and masks

The pandemic isn’t going to disappear from our lives. But if we take it seriously, it might not intrude on them quite so much.